company

GRØNTVEDT BIOTECH AS

7142 UTHAUG

Return on Equity
136,7 %
Current Ratio
0,49
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue888 000
Net Income−3 725 000
Total Assets10 893 000
Total Equity−2 725 000
Income (NOK)2022
Revenue888 000
Expenditure5 666 000
Operating Profit−4 777 000
Financial Income2 000
Financial Costs0
Financial Balance2 000
Earnings Before Tax−4 775 000
Tax−1 051 000
Net Income−3 725 000
Balance (NOK)2022
Total Fixed Assets4 180 000
Total Current Assets6 714 000
Total Assets10 893 000
Total Retained Equity−3 725 000
Total Equity−2 725 000
Total Long-Term Debt0
Total Current Debt13 618 000
Total Equity and Debt10 893 000
Cash flow (NOK)2022
Sales Income888 000
Other Income0
Revenue888 000
Cost of Goods Sold817 000
Salary Costs0
Depreciation0
Impairment0
Expenditure5 666 000
Operating Profit−4 777 000
Financial Income2 000
Financial Costs0
Financial Balance2 000
Dividends0
Net Income−3 725 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets1 051 000
Real Eastate0
Machinery and Plant Facilities3 129 000
Fixtures0
Total Tangible Assets3 129 000
Total Fiancial Fixed Assets0
Total Fixed Assets4 180 000
Stock1 943 000
Total Investments0
Cash, Bank0
Total Current Assets6 714 000
Total Assets10 893 000
Total Equity−2 725 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors12 598 000
Unpaid Taxes0
Dividends0
Other Current Debt1 020 000
Total Current Debt13 618 000
Total Equity and Debt10 893 000
Financial indicators2022
Return on Equity136,7 %
Debt-to-Equity Ratio−0
Operating Profit Margin−537,95 %
Current Ratio0,49
Quick Ratio0,58
Equity Ratio−0,25
Gross Profit Margin8 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English